ArticleOncotarget2012

A combination of temsirolimus, an allosteric mTOR inhibitor, with clofarabine as a new therapeutic option for patients with acute myeloid leukemia.

Francesca Chiarini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.